European Pharmaceutical Review

JULY 13, 2023

While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. Cannabis complications There are notable complexities to researching medical cannabis using a linear approach to clinical translation.

Compounding 98

Compounding Drug Development Clinical Pharmacology Documentation 98

RX Note

JANUARY 21, 2023

Adverse Drug Reaction Drug Induced Diseases, 2018 Meyler's Side Effects of Drugs, 2015 Antibiotics The Sanford Guide to Antimicrobial Therapy, 2022 Breastfeeding Briggs' Drugs in Pregnancy and Lactation, 2021 Hale's Medications and Mothers' Milk, 2021 Clinical Practice Applied Therapeutics, 2018 Conn’s Current Therapy, 2022 Current Medical Diagnosis (..)

Compounding 40

Compounding Community Pharmacies Clinical Pharmacology Dosage 40

European Pharmaceutical Review

MAY 2, 2023

billion in 2022, the average projected return on investment (ROI) in R&D was just 1.2 Clinical trials Growing internal capabilities Approximately 90 percent of the investment required to develop new medicines is the cost of conducting clinical trials. Available from: [link] Worldwide cancer statistics [Internet].

Clinical Pharmacology 105

Clinical Pharmacology Compounding Communication Pharmaceutical Companies 105

Eye on FDA

JANUARY 5, 2022

FDA has scheduled the first advisory committee meetings of 2022. But before heading into 2022, it is perhaps time to take stock of AdComms and what they did or did not do during 2021. Fewer Meetings. First and foremost is that as noted earlier this year (See August 5, 2021 FDA Adcomms – Is FDA Getting Less Advice?

Clinical Pharmacology 76

Clinical Pharmacology Vaccines Compounding Diabetes 76

Pharmaceutical Technology

DECEMBER 16, 2022

Pharmaceutical Technology lists some of the top events in the tropical disease arena in 2022. This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology.

Drug Development 105

Drug Development Vaccines Clinical Pharmacology Compounding 105